Pierre P. Massion

Vanderbilt University Medical Center, Vanderbilt University

Papers

2

Total Citations

33

H-Index

2

About

Pierre P. Massion is a leading pulmonary and critical care physician-scientist whose research centers on the early detection, diagnosis, and treatment of lung cancer. His major contributions lie in advancing minimally invasive surgical approaches for early-stage non-small cell lung cancer (NSCLC), particularly through comparative effectiveness studies of robotic-assisted versus video-assisted thoracoscopic lobectomy. His 2020 work, with 17 citations, directly addressed FDA safety concerns by demonstrating comparable short- and long-term mortality between these techniques, providing critical evidence for clinical decision-making. Massion’s broader impact is reflected in his highly cited chapter "Cancer of the Lung" (2014, 16 citations), a foundational resource for clinicians and trainees. His research has shaped modern thoracic oncology by integrating surgical innovation with rigorous outcomes analysis, improving survival and quality of life for lung cancer patients. As a mentor and investigator, Massion continues to drive translational research that bridges surgical technique and patient-centered care, making him a pivotal figure in the fight against lung cancer.

Research Focus

Key Achievements

2
H-Index
2
Papers
33
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Mortality for robotic- versus video-assisted lobectomy treated stage I non-small cell lung cancer patients
17 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Vanderbilt University Medical Center, Vanderbilt University

Top Papers

  1. 1
  2. 2
    Cancer of the Lung
    16 citations · 2014

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago